The effect of sample medication use on subsequent anti-VEGF agent selection for neovascular age-related macular degeneration
View ORCID ProfileKaren M. Wai, View ORCID ProfileTedi Begaj, Sachi Patil, Evan Chen, John B. Miller, View ORCID ProfileJan Kylstra, View ORCID ProfileMary E. Aronow, View ORCID ProfileLucy H. Young, View ORCID ProfileRachel Huckfeldt, View ORCID ProfileDeeba Husain, View ORCID ProfileLeo A. Kim, View ORCID ProfileDemetrios G. Vavvas, View ORCID ProfileDean Eliott, Shizuo Mukai, View ORCID ProfileEvangelos S. Gragoudas, View ORCID ProfileNimesh A. Patel, View ORCID ProfileLucia Sobrin, View ORCID ProfileJoan W. Miller, View ORCID ProfileRavi Parikh, View ORCID ProfileDavid M. Wu
doi: https://doi.org/10.1101/2021.07.27.21261104
Karen M. Wai
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Tedi Begaj
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Sachi Patil
2Department of Ophthalmology and Visual Sciences, New York University School of Medicine, New York, New York
Evan Chen
3Department of Ophthalmology, University of California, San Francisco, California
John B. Miller
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Jan Kylstra
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Mary E. Aronow
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Lucy H. Young
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Rachel Huckfeldt
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Deeba Husain
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Leo A. Kim
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Demetrios G. Vavvas
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Dean Eliott
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Shizuo Mukai
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Evangelos S. Gragoudas
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Nimesh A. Patel
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Lucia Sobrin
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Joan W. Miller
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Ravi Parikh
2Department of Ophthalmology and Visual Sciences, New York University School of Medicine, New York, New York
4Manhattan Retina and Eye Consultants, New York, New York
David M. Wu
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
Article usage
Posted July 30, 2021.
The effect of sample medication use on subsequent anti-VEGF agent selection for neovascular age-related macular degeneration
Karen M. Wai, Tedi Begaj, Sachi Patil, Evan Chen, John B. Miller, Jan Kylstra, Mary E. Aronow, Lucy H. Young, Rachel Huckfeldt, Deeba Husain, Leo A. Kim, Demetrios G. Vavvas, Dean Eliott, Shizuo Mukai, Evangelos S. Gragoudas, Nimesh A. Patel, Lucia Sobrin, Joan W. Miller, Ravi Parikh, David M. Wu
medRxiv 2021.07.27.21261104; doi: https://doi.org/10.1101/2021.07.27.21261104
The effect of sample medication use on subsequent anti-VEGF agent selection for neovascular age-related macular degeneration
Karen M. Wai, Tedi Begaj, Sachi Patil, Evan Chen, John B. Miller, Jan Kylstra, Mary E. Aronow, Lucy H. Young, Rachel Huckfeldt, Deeba Husain, Leo A. Kim, Demetrios G. Vavvas, Dean Eliott, Shizuo Mukai, Evangelos S. Gragoudas, Nimesh A. Patel, Lucia Sobrin, Joan W. Miller, Ravi Parikh, David M. Wu
medRxiv 2021.07.27.21261104; doi: https://doi.org/10.1101/2021.07.27.21261104
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (182)
- Cardiovascular Medicine (2675)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12295)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4144)
- Geriatric Medicine (388)
- Health Economics (683)
- Health Informatics (2687)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3927)
- Nursing (212)
- Nutrition (584)
- Oncology (2065)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1126)
- Primary Care Research (461)
- Public and Global Health (6567)
- Radiology and Imaging (1416)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)